Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001047469-17-005027
Filing Date
2017-08-04
Accepted
2017-08-04 17:28:38
Documents
9
Period of Report
2017-07-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a2232891z8-ka.htm 8-K/A 21868
2 EX-23.1 a2232891zex-23_1.htm EX-23.1 3891
3 EX-99.1 a2232891zex-99_1.htm EX-99.1 271663
4 EX-99.2 a2232891zex-99_2.htm EX-99.2 430528
5 EX-99.3 a2232891zex-99_3.htm EX-99.3 254010
6 EX-99.4 a2232891zex-99_4.htm EX-99.4 354671
7 G92101.JPG g92101.jpg GRAPHIC 6153
8 G371728.JPG g371728.jpg GRAPHIC 6572
9 G879247.JPG g879247.jpg GRAPHIC 8813
  Complete submission text file 0001047469-17-005027.txt   1367887
Mailing Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105
Business Address 201 MISSION STREET, SUITE 2375 SAN FRANCISCO CA 94105 415-896-5081
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36714 | Film No.: 171009582
SIC: 2834 Pharmaceutical Preparations